Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a performance status score of 0 to 2 on a standard scale used by doctors to measure how well a person is able to carry out daily activities (confirm with trial site)
- People who have been confirmed by tissue testing to have cervical cancer after having a hysterectomy, where the cancer has certain intermediate or high-risk features that mean radiation treatment to the pelvis is needed, with or without chemotherapy
- People who have been confirmed by tissue testing to have endometrial (uterine) cancer after having a hysterectomy, where radiation treatment to the pelvis is needed after surgery, with or without chemotherapy, and with or without internal radiation treatment to the vagina
Who may not be able to join:
- People who had visible cancer remaining in the body after their surgery
- People whose cancer has spread to lymph nodes near the large abdominal blood vessel (the aorta), requiring a wider area of radiation treatment than standard pelvic radiation
- People who have previously received chemotherapy for any cancer at any point in their life
- People who have previously had radiation treatment to the pelvic area
- People who have HIV infection
- People who have pre-existing health conditions that could affect the assessment of bowel or bladder side effects during the trial, such as irritable bowel syndrome, partial bowel blockage, bowel incontinence, hemorrhoids that would make bowel assessments difficult, urinary incontinence, or recurring urinary tract infections
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr. Prachi D Mittal, MD, Tata Memorial Hospital
Phone: +91 9004938871
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-year cumulative incidence of grade ≥2 gastrointestinal or genitourinary toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.